Neuroprotective effects of PPARγ agonists against oxidative insults in HT-22 cells

European Journal of Pharmacology

Volumn 472, Issue 1-2, 2003, Pages 65-71

  Aoun, Paul ^a   Watson, David G ^a   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

15 Deoxy prostaglandin J2; Neuroprotection; Peroxisome proliferator activated receptor; Thiazolidinedione; Troglitazone

Indexed keywords

3 CHLORO 4 [3 (7 PROPYL 3 TRIFLUOROMETHYLBENZISOXAZOL 6 YLOXY)PROPYLTHIO]PHENYLACETIC ACID; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; ALITRETINOIN; CALCEIN; CIGLITAZONE; DELTA15 PROSTAGLANDIN J2; DNA; GLUTAMIC ACID; HYDROGEN PEROXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIRINIXIC ACID; TROGLITAZONE; UNCLASSIFIED DRUG; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL RECEPTOR; CHROMAN DERIVATIVE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; PROSTAGLANDIN D2; RETINOIC ACID; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; ASSAY; CELL CULTURE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG INTERACTION; DRUG POTENTIATION; OXIDATION REDUCTION REACTION; TIME;

ANIMALS; CELL LINE; CELL SURVIVAL; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLUTAMIC ACID; HUMANS; HYDROGEN PEROXIDE; MICE; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0038153961     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01867-3     Document Type: Article

References (32)

1. Benson S., Padmanabhan S., Kurtz T.W., Pershadsingh H.A. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells. Mol. Cell. Biol. Res. Commun. 3(3):2000;159-164.
2. Berger J., Leibowitz M.D., Doebber T.W., Elbrecht A., Zhang B., Zhou G., Biswas C., Cullinan C.A., Hayes N.S., Li Y., Tanen M., Ventre J., Wu M.S., Berger G.D., Mosley R., Marquis R., Santini C., Sahoo S.P., Tolman R.L., Smith R.G., Moller D.E. Novel peroxisome proliferator-activated receptor (PPAR)γ and PPARδ ligands produce distinct biological effects. J. Biol. Chem. 274(10):1999;6718-6725.
3. Chawla A., Schwartz E.J., Dimaculangan D.D., Lazar M.A. Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipose differentiation. Endocrinology. 135:1994;798-800.
4. Cherubini A., Polidori M.C., Bregnocchi M., Pezzuto S., Cecchetti R., Ingegni T., Di Iorio A., Senin U., Mecocci P. Antioxidant profile and early outcome in stroke patients. Stroke. 31:2000;2295-2300.
5. Dreyer C., Krey G., Keller H., Givel F., Helfetbein G., Wahli W. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
6. Dubey R.K., Zhang H.Y., Reddy S.R., Boegehold M.A., Kotchen T.A. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am. J. Physiol. 265:1993;R726-R732.
7. Dussault I., Forman B.M. Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator-activated receptor nuclear receptors. Prostaglandins Other Lipid Mediat. 62:2000;1-13.
8. Elangbam C.S., Tyler R.D., Lightfoot R.M. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation - an update. Toxicol. Pathol. 29(2):2001;224-231.
9. Heneka M.T., Feinstein D.L., Galea E., Gleichmann M., Wullner U., Klockgether T. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J. Neuroimmunol. 100(1-2):1999;156-168.
10. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
11. Jenner P., Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47:1996;S161-170.
12. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83:1995;813-819.
13. Krey G., Braissant O., L'Horest F., Kalkhoven E., Perroud M., Parker M.G., Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11:1997;779-791.
14. Law R.E., Meehan W.P., Xi X.P., Graf K., Wuthrich D.A., Coats W., Faxon D., Hsueh W.A. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1996;1897-1905.
15. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkinson W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270(10):1995;12953-12956.
16. Lemberger T., Braissant O., Juge-Aubry C., Keller H., Saladin R., Steals B., Auwerx J., Burger A., Meier C.A., Wahli W. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. N.Y. Acad. Sci. 804:1996;231-251.
17. Li Y., Maher P., Schubert D. A role of 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 19:1997;453-463.
18. Maher P., Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16:1996;6394-6401.
19. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
20. Miller T.M., Johnson E.M. Jr. Metabolic and genetic analyses of apoptosis in potassium/serum-deprived rat cerebellar granule cells. J. Neurosci. 16(23):1996;7487-7495.
21. Morimoto B.H., Koshland D.E. Jr. Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line. Neuron. 5:1990;875-880.
22. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
23. Nishijima C., Kimoto K., Arakawa Y. Survival activity of troglitazone in rat motoneurones. J. Neurochem. 76:2001;382-390.
24. 12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-γ, induces neuronal apoptosis. Mol. Neurosci. 12(4):2001;839-843.
25. Rossi A., Kapahi P., Natili G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB. Nature. 403:2000;103-108.
26. Rudich A., Tirosh A., Potashnik R., Khamaisi M., Bashan N. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia. 42:1999;949-957.
27. Sundararajan S., Wandery E., Lust W.D., Landreth G.E. A PPARγ agonist reduces infarct size and improves functional outcome following focal ischemia. Soc. Neurosci. Abstr. 2001;864.4.
28. Tan S., Sagara Y., Liu Y., Maher P., Schubert D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141(6):1998;1423-1432.
29. Tan S., Wood M., Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71:1998;95-105.
30. Tanabe H., Eguchi Y., Shimizu S., Martinou J.-C., Tsujimoto Y. Death-signaling cascade in mouse cerebellar granule neurons. Eur. J. Neurosci. 10:1998;1403-1411.
31. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 79:1994;124-130.
32. Uryu S., Harada J., Hisamoto M., Oda T. Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons. Brain Res. 924(2):2002;229-236.